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Abstract
Background: While rates of postpartum haemorrhage (PPH) have continued to rise, it is not clear if the association
with other morbidity and transfusion has changed over time. This study explores the recent trend in postpartum
haemorrhage and whether postpartum haemorrhage is associated with increased transfusions or adverse outcomes
over time.
Methods: Linked birth and hospital data were used to examine ICD-10 AM coded PPH and outcomes in maternal
birth admission records, 2003-–2011 in hospitals in New South Wales (NSW), Australia (N = 818,965 pregnancies).
Trends were calculated on the whole population, and among subgroups, and tested using the Cochran Armitage
test for trend. Logistic regression models were developed separately for vaginal and caesarean births, and for a
maternal morbidity composite indicator (excluding transfusion) and red cell transfusion. Adjusted odds ratios (aOR)
for each year relative to 2003 and 95 % confidence intervals (CI) are presented with adjustment for maternal (eg.
age, country of birth) and pregnancy factors (eg. parity, interventions, pregnancy complications).
Results: Overall, there was a significant increase in the PPH rate, from 6.1 % in 2003 to 8.3 % in 2011 (p < 0.0001).
Crude rates of postpartum haemorrhage with transfusion increased from 0.75 % (n = 636) to 1.21 % (n = 1145)
(p < 0.0001) while crude rates of postpartum haemorrhage with maternal morbidity increased from 0.18 % (n = 149) to
0.23 % (n = 221) (p = 0.02). Having accounted for maternal and pregnancy factors, there were significant overall
decreases in the odds of morbidity among women with a PPH delivering vaginally (in 2006, 2007 and 2010, aORs
were 0.70 (95 % CI 0.52, 0.96) 0.69 (0.51, 0.94) and 0.64 (0.47, 0.87) relative to 2003; p < 0.05), and no significant decrease
among women delivered by caesarean section (aOR 0.87 (0.58, 1.29) in 2011; p = 0.37). Among women with a PPH
delivering vaginally, there was a trend towards a non-linear increase in the adjusted odds of transfusion by birth year.
Compared to women who had vaginal births with PPH in 2003, the adjusted odds for transfusion was between 1.1 and
1.2 fold higher for those with a PPH delivering vaginally in 2007, 2009, 2010 and 2011. However there was no significant
trend amongst caesarean births (aOR 0.84 (0.66, 1.06) in 2011; p = 0.29).
Conclusions: PPH has become more frequent, however this has not been associated with a clear pattern of increased
severe maternal morbidity. This suggests that the increase in PPH may represent fewer severe haemorrhages, better
management of severe haemorrhage or better recording of PPH. The increase in transfusions following vaginal births
with PPH warrants further investigation.
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Background
Postpartum haemorrhage rates have increased in the
developed world [1]. At the same time, transfusion rates
associated with childbirth have risen in Australia [2],
Canada [3] and the United States [4]. It is unclear whether
the increased rates of postpartum haemorrhage represent
more severe haemorrhage. In Australia, the postpartum
haemorrhage rate increased by around 25 % from 1994 to
2002. During this period, the transfusion rate among
women with postpartum haemorrhage increased by 500 %
(from 2 to 12 %) [5]. Obstetric transfusions (not limited to
women with postpartum haemorrhage) increased from
1.2 % of births in 2001 to 1.6 % of births in 2010 [2].
Current population-based pregnancy and birth data do
not include details of the amount of blood lost at post-
partum haemorrhage, nor the quantity of blood trans-
fused. In the absence of these details, post-haemorrhage
outcomes such as maternal morbidity and transfusion
may provide insight into whether bleeding is becoming
more severe over time. Given increasing caesarean sec-
tion rates and different risk factors reportedly associated
with vaginal and caesarean births [6, 7], it is worthwhile
considering the outcomes following postpartum haemor-
rhage separately for these birth modes.
The aims of this study were to determine the recent
trend in postpartum haemorrhage and whether postpar-
tum haemorrhage is associated with increased transfu-
sions or severe adverse outcomes over time.
Methods
The study population consisted of all women with live-
births or stillborn infants of at least 20 weeks gestation
in New South Wales (NSW) hospitals between 2003 and
2011. Data on maternal demographics, the pregnancy,
labour and birth were obtained from the Perinatal Data
Collection (‘Birth data’). This is a legislated statewide rec-
ord of all births in NSW, and is completed by the midwife
or doctor at the time of birth. Data on maternal diagnoses
and procedures were obtained from the Admitted Patients
Data Collection (‘Hospital data’), which contains data
collected on all private and public hospital discharges in
NSW. Diagnoses and procedures associated with hospital
discharges are coded according to the 10th revision of the
International Classification of Diseases, Australian Modifi-
cation (ICD10-AM) [8] and the Australian Classification
of Health Interventions (ACHI) [9] respectively.
The Centre for Health Record Linkage performed
probabilistic linkage of the hospital and birth data, to
assign unique project identifiers to each mother, allow-
ing both longitudinal linkage of pregnancies and hospita-
lisations during and following pregnancy. For this study,
rates of missed and incorrect links were less than 0.5 %.
Postpartum haemorrhage was identified from the hos-
pital data using ICD codes (O72 and subcodes). Blood
loss of equal or greater than 500 mL following a vaginal
birth, or equal or greater than 750 mL following a
caesarean birth is classified as a postpartum haemorrhage
[10]. Validation studies have indicated that postpartum
haemorrhage is accurately reported, although under-
enumerated with sensitivity and specificity of 73.8 % and
98.9 %, respectively [11]. Previous postpartum haemorrhage
was defined as a postpartum haemorrhage reported in any
previous pregnancy (since July 2001) and was obtained
from the longitudinal linkage of a woman’s pregnancies.
Outcomes of interest were severe maternal morbidity
and blood transfusion. Maternal morbidity was mea-
sured using a validated composite indicator of adverse
outcomes [12]. This indicator includes the following
diagnoses: acute abdomen, acute renal failure, acute
pyschosis, cardiac arrest, cerebral oedema or coma, dis-
seminated intravascular coagulopathy, cerebro-vascular
accident, major complications of anaesthesia, obstetric
embolism, shock, status asthmaticus or epilepticus or
uterine rupture; as well as procedures including: assisted
ventilation, dialysis, evacuation of haematoma, hysterec-
tomy, dilatation and curettage (with general anaesthetic),
procedures to reduce blood flow to uterus, reclosure of
disrupted CS wound, repair of bladder or cytostomy, re-
pair of intestine or repair of ruptured or inverted uterus.
The original indicator included blood transfusion as a
component of morbidity, however this was excluded
from the criteria for morbidity and examined separately
for this study. Use of a composite indicator overcomes the
under-ascertainment of individual diagnoses and proce-
dures [13]. Blood transfusion was defined in this study as
transfusion of whole blood or red blood cells (ACHI
13706-01, 13706-02) [9], which is well reported (sensitivity
and specificity of 83.1 % and 99.9 %, respectively) [11].
Since we were interested in trends in transfusion and
morbidity, women experiencing both a transfusion and a
morbidity diagnosis were included in both the transfusion
and morbidity outcomes. A sensitivity analysis was per-
formed to assess whether estimates changed when transfu-
sion and morbidity were treated as mutually exclusive
outcomes.
Maternal demographics, pregnancy, labour and delivery
data were obtained from the birth data; chronic conditions
(chronic hypertension, diabetes, renal and cardiac condi-
tions), antepartum haemorrhage (APH), morbidly adher-
ent placenta, and placenta praevia were obtained from the
hospital data; and pregnancy hypertension and gestational
diabetes were obtained from either birth or hospital data
based on validation studies indicating the most reliably
reported sources [11, 14–17]. Pregnancy, labour and
delivery data have been shown to be well reported in these
datasets [18, 19].
Trends were calculated on the whole population
(including multifetal pregnancies), and among subgroups,
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and tested using the Cochran Armitage test for trend.
Logistic regression models were developed to assess the
change in severity of postpartum haemorrhage over time
(measured by maternal morbidity or transfusion)
among birth admissions for women delivering a single-
ton infant and experiencing a postpartum haemor-
rhage. Modelling was restricted to singleton births
given the different risk profile of women with multi-
fetal pregnancies. Models were developed separately
for vaginal and caesarean births given the different
blood loss criteria for postpartum haemorrhage diag-
nosis in Australian data (≥500 mls post-vaginal birth,
≥750 mls post-caesarean). Separate models were also
developed for maternal morbidity and transfusion. All
available risk factors for morbidity/ transfusion were
entered into the multivariable models. A sensitivity
analysis was also performed including diagnosis codes for
placenta praevia with haemorrhage as part of the defin-
ition of a postpartum haemorrhage, however associations
were unchanged so this analysis has not been included.
All analysis was conducted in SAS 9.3. Ethics approval
was from the NSW Population and Health Services
Research Ethics Committee who deemed that individual
consent was not required for this study (#2006-06-011).
Results
Between 2003 and 2011 there were 818,965 births in
New South Wales. Overall, a postpartum haemorrhage
was reported in 59,639 (7.3 %) of births. There was a sig-
nificant increase in the postpartum haemorrhage rate,
from 6.1 % (n = 5158) in 2003 to 8.3 % (n = 7886) in
2011 (p < 0.0001). Rates of postpartum haemorrhage
with transfusion increased from 0.75 % (n = 636) to
1.21 % (n = 1145) (p < 0.0001) while rates of postpartum
haemorrhage with maternal morbidity increased from
0.18 % (n = 149) to 0.23 % (n = 221) (p = 0.02). Among
caesarean births, the rate of postpartum haemorrhage
increased by 55 % (3.7 % to 5.7 %), whereas among
vaginal births they increased by 36 % (7.0 % to
9.5 %) (Figs. 1 and 2). Women with a postpartum
haemorrhage were more likely to have multifetal
pregnancies, be primiparous, have pregnancy hyper-
tension, antepartum haemorrhage, instrumental de-
livery and large-for-gestational age infants, and were
less likely to be a private patient. Women with a
previous postpartum haemorrhage were more likely
to have a postpartum haemorrhage in the current
pregnancy than women without a history of post-
partum haemorrhage (Table 1).
Fig. 1 Trends in postpartum haemorrhage, adverse maternal outcomes (MMOI) and red cell transfusion rates among vaginal births in NSW, 2003–2011.
MMOI – Maternal morbidity outcome indicator
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Subsequent morbidity among women with a postpartum
haemorrhage
There was no significant change in the crude maternal
morbidity rate (excluding transfusion) among all
women with a postpartum haemorrhage (p = 0.28) (2.9
per 100 births to 2.8 per 100 births). Having accounted
for maternal and pregnancy factors, there were signifi-
cant decreases in the odds of morbidity among women
with a postpartum haemorrhage (PPH) delivering
vaginally (in 2006, 2007 and 2010 aORs were 0.70 (0.52,
0.96), 0.69 (0.51, 0.94) and 0.64 (0.47,0.87) relative to
2003; p < 0.05), and no significant decrease among
women delivering by caesarean section (aOR 0.87 (0.58,
1.29) in 2011 compared to 2003; p = 0.37) (Table 2).
Morbidity or transfusion was more common among
women with postpartum haemorrhage in the context of
multiple birth, previous caesarean, previous PPH, placenta
praevia and morbidly adherent placenta (Additional file 1:
Table S1). Risk factors for maternal morbidity among
women with a postpartum haemorrhage were similar for
those giving birth vaginally and by caesarean section.
These risk factors included advanced maternal age
(>35 years), women with chronic conditions, maternal
birth outside Australia, preterm birth, placenta praevia,
morbidly adherent placenta, pregnancy hypertension,
and women with a history of postpartum haemorrhage.
Instrumental deliveries were associated with higher
morbidity among vaginal births (Table 2).
Transfusion among women with a postpartum
haemorrhage
There was a significant increase in the red cell transfu-
sion rate (p < 0.001) among all women with a post-
partum haemorrhage from 12.3 per 100 births in 2003
to 14.5 per 100 births in 2011. Among women with a
PPH delivering vaginally, there was a trend towards a
non-linear increase in the adjusted odds of transfusion
by birth year. Compared to women who had vaginal
births with PPH in 2003, the adjusted odds for transfu-
sion was between 1.1 and 1.2 fold higher for those with
a PPH delivering vaginally in 2007, 2009, 2010 and
2011There was no significant trend amongst caesarean
births with postpartum haemorrhage (aOR 0.84 (0.66,
1.06) in 2011 relative to 2003; p = 0.29) (Table 3). Risk
factors for blood transfusion following postpartum
haemorrhage included the extremes of maternal age,
preterm birth, morbidly adherent placenta, placenta
praevia, antepartum haemorrhage, induction of labour,
previous postpartum haemorrhage, and delivery in a
regional hospital. For vaginal deliveries, instrumental
births, pregnancy hypertension, smoking and previous
caesarean section were also risk factors. For caesarean
births, higher parity was associated with increased risk
of transfusion (Table 3).
A sensitivity analysis (data not shown) was performed
in which women experiencing both a transfusion and
morbidity (n = 925) were only included in the morbidity
Fig. 2 Trends in postpartum haemorrhage, adverse maternal outcomes (MMOI) and red cell transfusion rates among caesarean section births in
NSW, 2003–2011. MMOI – Maternal morbidity outcome indicator
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outcome. The increase in blood transfusion persisted
but was slightly attenuated (10.7 to 12.7 per 100 births;
p < 0.001). The adjusted morbidity and transfusion
trends were unchanged.
Discussion
This population-based study found not only had post-
partum haemorrhage rates increased between 2003 and
2011, but that the increase over this 9 year period was
Table 1 Maternal and pregnancy characteristics of women with and without postpartum haemorrhage (PPH), NSW, 2003–2011
Variable Postpartum haemorrhage (N = 59,639) No postpartum haemorrhage (N = 759,326)
Maternal age (years)
Under 20 2386 (4.0) 27407 (3.6)
20–34 45012 (75.5) 562067 (74.0)
35+ 12241 (20.5) 169852 (22.4)
Smoker 6524 (10.9) 88992 (11.7)
Australian born 38530 (64.6) 523266 (68.9)
Multiple birth 1647 (2.8) 10927 (1.4)
Parity
1st 29179 (48.9) 317620 (41.8)
2nd-4th 28021 (47.0) 412846 (54.4)
5+ 2366 (4.0) 27588 (3.6)
Previous Caesarean 5489 (9.2) 111610 (14.7)
Gestational diabetes 3842 (6.4) 45688 (6.0)
Pregnancy hypertension 6740 (11.3) 69387 (9.1)
Antepartum haemorrhage 2440 (4.1) 19246 (2.5)
Malpresentation 2037 (3.4) 35981 (4.7)
Previous PPH 10823 (18.1) 27116 (3.6)
Placenta praevia 1253 (2.1) 7678 (1.0)
Morbidly adherent placenta 1163 (2.0) 826 (0.1)
Gestational age (weeks)
20–32 1372 (2.3) 11654 (1.5)
33–36 3023 (5.1) 37969 (5.0)
37+ 55244 (92.6) 709703 (93.5)
Mode of birth
Normal vaginal delivery 36717 (61.6) 451652 (59.5)
Caesarean 11860 (19.9) 228010 (30.0)
Caesarean without labour 5465 (9.2) 133292 (17.6)
Caesarean with labour 6393 (10.7) 94704 (12.5)
Instrumental delivery 11186 (18.8) 80382 (10.6)
Forceps 4802 (8.1) 26272 (3.5)
Vacuum 6384 (10.7) 54110 (7.1)
Induction of labour 20479 (34.3) 202866 (26.7)
Large for gestational age 9197 (15.4) 78804 (10.4)
Hospital type
Tertiary 31503 (52.8) 307664 (40.5)
Regional 11561 (19.4) 161522 (21.3)
Urban/other 8754 (14.7) 99859 (13.2)
Private 7821 (13.1) 190281 (25.1)
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Table 2 Year of birth and maternal morbiditya among women with a singleton pregnancy and postpartum haemorrhage, NSW,
2003–2011
Vaginal births N = 46955 Caesarean births N = 11037
Unadjusted OR Adjusted ORb Unadjusted OR Adjusted ORb
Year of birth
2003 Ref Ref Ref Ref
2004 0.87 (0.65, 1.17) 0.90 (0.66, 1.21) 1.20 (0.80, 1.79) 1.13 (0.74, 1.72)
2005 0.76 (0.56, 1.03) 0.79 (0.58, 1.08) 1.16 (0.78, 1.71) 1.14 (0.76, 1.73)
2006 0.70 (0.52, 0.94) 0.70 (0.52, 0.96) 1.13 (0.77, 1.65) 1.03 (0.69, 1.55)
2007 0.70 (0.52, 0.94) 0.69 (0.51, 0.94) 1.30 (0.89, 1.90) 1.10 (0.73, 1.65)
2008 0.93 (0.70, 1.22) 0.90 (0.78, 1.20) 1.18 (0.81, 1.73) 1.04 (0.69, 1.55)
2009 0.91 (0.69, 1.20) 0.91 (0.69, 1.21) 1.00 (0.69, 1.46) 0.87 (0.58, 1.30)
2010 0.65 (0.48, 0.88) 0.64 (0.47, 0.87) 0.78 (0.53, 1.16) 0.67 (0.44, 1.01)
2011 0.86 (0.65, 1.13) 0.86 (0.65, 1.14) 1.02 (0.70, 1.48) 0.87 (0.58, 1.29)
Maternal Age
Under 20 1.02 (0.71, 1.46) 0.39 (0.14, 1.08)
20–34 Ref Ref
35+ 1.31 (1.10, 1.55) 1.16 (0.97, 1.40)
Private patient 0.89 (0.69, 1.14) 0.92 (0.69, 1.21)
Smoker 1.02 (0.82, 1.27) 1.12 (0.86, 1.45)
Parity
1
2–4 0.87 (0.74, 1.03) 1.29 (1.04, 1.64)
5+ 0.80 (0.55, 1.17) 1.53 (1.04, 2.24)
Australian born 0.82 (0.70, 0.96) 0.72 (0.60, 0.87)
Gestational Age
20–32 weeks 2.43 (1.62, 3.65) 2.27 (1.61, 3.22)
33–36 weeks 1.28 (0.92, 1.79) 1.52 (1.16, 1.98)
37+ weeks Ref Ref
Mode of birth
Vaginal Ref
Forceps 1.19 (0.95, 1.50) .
Vacuum 1.14 (0.92, 1.41) .
Caesarean in labour 1.64 (1.32, 2.03)
Pre-labour caesarean
Induction 1.10 (0.95, 1.27) 1.31 (1.03, 1.67)
Large for gestational age 0.84 (0.68, 1.04) 0.82 (0.65, 1.03)
Chronic conditions 2.94 (2.08, 4.14) 2.07 (1.45, 2.97)
Pregnancy factors
Antepartum haemorrhage 1.42 (1.02, 1.96) 1.04 (0.78, 1.39)
Previous caesarean 1.77 (1.33, 2.35) 1.80 (1.43, 2.26)
Previous PPH 1.48 (1.25, 1.75) 1.75 (1.44, 2.12)
Malpresentation 1.39 (0.59, 3.28) 1.01 (0.78, 1.29)
Morbidly adherent placenta 4.25 (3.20, 5.64) 10.21 (7.78, 13.40)
Placenta praevia 2.31 (1.80, 2.96)
Gestational diabetes 1.12 (0.85, 1.46) 0.94 (0.70, 1.27)
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proportionally higher than previously reported [20]
(36 % increase compared to 25 % in the previous 8 year
period). Although the largest number of postpartum
haemorrhages occurred among vaginal births in our
setting, the increase in the postpartum haemorrhage rate
was primarily driven by haemorrhage post-caesarean
birth. We found that while the postpartum haemorrhage
rate has continued to rise, among women experiencing a
haemorrhage post-vaginal birth there has been a de-
crease in maternal morbidity. However, transfusions
among women having a postpartum haemorrhage
following vaginal birth increased over the study period.
Despite known under-ascertainment of postpartum
haemorrhage for women delivered by caesarean section
[21], there are no known reporting changes over the
study period. Other studies reporting increases in overall
postpartum haemorrhage have not stratified by mode of
delivery so it is unknown whether this trend is mirrored
in other settings [1, 22]. A recent Canadian paper
suggested that post-caesarean atonic haemorrhage in-
creased by 95 % from 2001 to 2009 while post-vaginal
delivery atonic haemorrhage increased by 35 % [3]. We
have previously demonstrated misclassification of report-
ing on PPH cause using ICD reporting, in particular
over-estimation of the contribution of uterine atony to
PPH [23]. There are no known practice changes associ-
ated with caesarean delivery over this period that explain
increased haemorrhage rates.
Reassuringly, morbidity rates post-haemorrhage do not
appear to have increased, and among vaginal deliveries
decreased over the study period. This suggests that the
increase in postpartum haemorrhage does not represent
an increase in severe haemorrhage resulting in life-
threatening complications. While more postpartum hae-
morrhages have been identified, the management of
these may be preventing deterioration into severe mor-
bidity. Population data do not include detailed informa-
tion on staffing or timing of interventions that may have
contributed to decreasing maternal morbidity over the
period. Previously, postpartum haemorrhage was reported
to be driving up rates of maternal morbidity in Australia
[13]; importantly, this previous study included transfusion
as part of the composite measure of maternal morbidity,
whereas for the current study we have investigated trans-
fusion separately.
After adjustment for other risk factors, there was a sig-
nificant increase in red cell transfusions for vaginal
births, however there was no significant trend among
caesarean births. Given that the increase among vaginal
births occurred in the context of no increase in mor-
bidity, this may reflect an increased frequency of use of
red cell transfusion for less severe cases of haemor-
rhage post-vaginal delivery. It is not clear why an
increase in transfusions only occurred following post-
partum haemorrhage at vaginal birth (not following
caesareans); this may be related to different staff
making decisions about transfusions in the labour ward
versus theatre, differential use of point of care haemoglo-
bin testing and/or timing of access to additional blood loss
minimization techniques such as Bakri balloons.
The proportion of women with postpartum haemor-
rhage receiving transfusion had previously increased
dramatically (from 2 % in 1994 to 12 % in 2002) [5].
Our study suggests that a higher proportion of women
are now transfused (12 % in 2003 to 15 % in 2011),
however, the rate of increase is much less than previously
demonstrated. Without details on actual blood loss or
timing of transfusion (immediately post-delivery or a few
days postpartum) it is difficult to speculate about the
severity of haemorrhages being transfused. Nevertheless,
in the setting of increased obstetric transfusions [2] and
the largely unpredictable nature of postpartum haemor-
rhage, patient blood management strategies including
recognizing and treating antepartum anemia, active
management of the third stage of labour and use of
iron therapy in the setting of postpartum anemia are
worthwhile considerations for pregnant and recently
pregnant women.
While preterm birth and the presence of chronic
conditions increased the risk of morbidity following
Table 2 Year of birth and maternal morbiditya among women with a singleton pregnancy and postpartum haemorrhage, NSW,
2003–2011 (Continued)
Pregnancy hypertension 1.52 (1.24, 1.85) 1.58 (1.25, 1.98)
Hospital
Tertiary Ref Ref
Urban 1.15 (0.95, 1.41) 1.00 (0.76, 1.32)
Regional 1.16 (0.96, 1.41) 1.23 (0.95, 1.58)
Private 1.05 (0.77, 1.43) 1.29 (0.90, 1.85)
Numbers in bold represent statistically significant adjusted risk or protective factors for maternal morbidity. Chronic conditions included chronic hypertension,
pre-existing diabetes, renal disease, cardiac disease
aMaternal morbidity includes diagnoses such as shock, uterine rupture, and cerebrovascular accident as well as procedures including assisted ventilation, dialysis,
evacuation of haematoma, hysterectomy, dilatation and curettage under general anaesthesia. A full list of diagnoses and procedures is listed in the methods.
bAdjusted for all other variables in the column
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Table 3 Year of birth and red cell blood transfusion among women with a singleton pregnancy and postpartum haemorrhage, NSW,
2003–2011
Vaginal births N = 46955 Caesarean births N = 11037
Unadjusted OR Adjusted ORa Unadjusted OR Adjusted ORa
Year of birth
2003 Ref Ref Ref Ref
2004 1.03 (0.90, 1.18) 1.03 (0.90, 1.18) 0.91 (0.70, 1.17) 0.90 (0.67, 1.17)
2005 1.07 (0.94. 1.22) 1.08 (0.95, 1.24) 0.91 (0.70, 1.16) 0.92 (0.71, 1.18)
2006 1.13 (0.99, 1.28) 1.13 (0.99, 1.29) 0.92 (0.72, 1.16) 0.88 (0.68, 1.13)
2007 1.18 (1.04, 1.34) 1.15 (1.01, 1.31) 1.19 (0.94, 1.50) 1.11 (0.87, 1.42)
2008 1.08 (0.95, 1.22) 1.05 (0.92, 1.19) 1.01 (0.80, 1.26) 0.96 (0.75, 1.23)
2009 1.18 (1.04, 1.34) 1.15 (1.01, 1.31) 1.01 (0.80, 1.26) 0.97 (0.77, 1.24)
2010 1.20 (1.06, 1.36) 1.16 (1.02, 1.31) 0.96 (0.77, 1.21) 0.91 (0.72, 1.16)
2011 1.29 (1.15, 1.46) 1.23 (1.08, 1.39) 0.89 (0.71, 1.11) 0.84 (0.66, 1.06)
Maternal Age
Under 20 1.29 (1.14, 1.46) 1.99 (1.47, 2.69)
20–34 Ref Ref
35+ 1.11 (1.03, 1.20) 1.11 (0.99, 1.25)
Private patient 0.87 (0.78, 0.96) 0.93 (0.78, 1.10)
Smoker 1.16 (1.07, 1.27) 0.98 (0.83, 1.16)
Parity
1
2–4 0.79 (0.74, 0.85) 1.25 (1.09, 1.44)
5+ 0.84 (0.72, 0.99) 2.13 (1.68, 2.71)
Australian born 0.95 (0.89, 1.01) 0.74 (0.66, 0.83)
Gestational Age
20–32 weeks 1.21 (0.95, 1.54) 1.79 (1.40, 2.30)




Forceps 1.70 (1.55, 1.86)
Vacuum 1.32 (1.21, 1.43)
Caesarean in labour 1.57 (1.37, 1.79)
Pre-labour caesarean
Induction 1.12 (1.06, 1.19) 1.01 (0.87, 1.16)
Large for gestational age 1.09 (1.01, 1.18) 1.13 (0.99, 1.28)
Chronic conditions 1.27 (1.03, 1.57) 1.23 (0.94, 1.62)
Pregnancy factors
Antepartum haemorrhage 1.49 (1.30, 1.72) 1.47 (1.23, 1.76)
Previous caesarean 1.43 (1.25, 1.63) 1.03 (0.89, 1.19)
Previous PPH 1.40 (1.31, 1.51) 1.27 (1.12, 1.44)
Malpresentation 1.07 (0.68, 1.69) 1.03 (0.87, 1.20)
Morbidly adherent placenta 3.88 (3.32, 4.53) 5.21 (4.06, 6.68)
Placenta praevia 3.09 (2.62, 3.65)
Gestational diabetes 1.00 (0.89, 1.13) 0.92 (0.76, 1.10)
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postpartum haemorrhage, even when these factors were
taken into account, women with a previous caesarean
birth or previous birth complicated by postpartum
haemorrhage remained at increased risk of subsequent
morbidity. The role previous birth complications play in
index birth complications is increasingly being recognised
[24, 25] and underlines the importance of recording and
taking into account obstetric history when caring for mul-
tiparous women.
Strengths of this study include the use of validated
population-based data to investigate rare outcomes in-
cluding severe adverse maternal outcomes and transfu-
sion as well as the incorporation of previous obstetric
history. Using record linkage we have been able to take
into account previous postpartum haemorrhage and
previous caesarean, although for the earlier years of the
study only a two year lookback period was available. The
two outcomes considered in this study may be inter-
related –a transfusion in some cases is likely to have
prevented further morbidity. Nevertheless, there are
known limitations to using administrative datasets in-
cluding under-enumeration of haemorrhage, transfusion
and other adverse outcomes as well as difficulties in
establishing temporality of events. While the amount of
blood loss is likely under-estimated [26], more severe
haemorrhage is more likely to be reported [11]. Based on
previously demonstrated differential under-enumeration
of postpartum haemorrhage by mode of delivery [21], we
examined outcomes separately following vaginal and
caesarean births. However, incidence rates of postpartum
haemorrhage, particularly following caesarean birth, may
be under-enumerated.
Conclusions
While women giving birth today are more likely to have
a postpartum haemorrhage, on the whole they are no
more likely to experience severe adverse outcomes sub-
sequent to the haemorrhage than in 2003. The increase
in post-caesarean haemorrhage highlights the need for
vigilance in the operative setting. The increase in red cell
transfusions following vaginal birth with postpartum
haemorrhage warrants further investigation. The increase
in PPH with a decrease in severe maternal morbidity
(particularly among vaginal births) may represent fewer
severe haemorrhages, better management of severe
haemorrhage or better recording of PPH. Further
insight into the severity of postpartum haemorrhages in
the Australian setting will soon be available via record
linkage that allows number of units transfused to each
woman to be assessed.
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